HomeCRVS • NASDAQ
add
Corvus Pharmaceuticals Inc
Previous close
$1.73
Day range
$1.75 - $2.08
Year range
$1.05 - $4.19
Market cap
94.15M USD
Avg Volume
177.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.63M | 2.01% |
Net income | -6.65M | 32.22% |
Net profit margin | — | — |
Earnings per share | -0.14 | 33.75% |
EBITDA | -5.60M | -3.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 27.15M | -35.82% |
Total assets | 45.55M | -33.25% |
Total liabilities | 6.87M | -43.35% |
Total equity | 38.68M | — |
Shares outstanding | 49.04M | — |
Price to book | 2.19 | — |
Return on assets | -28.87% | — |
Return on capital | -32.71% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.65M | 32.22% |
Cash from operations | -5.17M | 31.54% |
Cash from investing | -2.32M | 40.29% |
Cash from financing | 0.00 | — |
Net change in cash | -7.48M | 34.51% |
Free cash flow | -3.27M | 42.82% |
About
Founded
2014
Headquarters
Website
Employees
28